Which portfolio companies can document repeatable customer deployment and sustained commercial adoption beyond research partnerships?
What evidence would help
A source addressing this question must identify the named system, experiment or deployment, its conditions, measured outcome and remaining limitations. Do named recipients confirm the support or program outcome?
What would resolve it?
An editorial review must explain which part of this question the evidence resolves. A roadmap or an announcement alone does not close it.
No resolved, partial or disputed outcome is asserted without a reviewed transition and its evidence.